The p53 gene was analyzed in tumor specimens obtained from 52 patients with various types of carcinoma of the thyroid gland by a combined molecular and immunocytochemical approach. The histologic types included 37 well-differentiated papillary and follicular carcinomas, 8 poorly differentiated, and 7 undifferentiated carcinomas. The p53 gene was shown to be unaffected in all differentiated tumors by single-strand conformation polymorphism analysis. However, in two out of eight (25%) of poorly differentiated carcinomas and five out of seven (71%) undifferentiated carcinomas, p53 mutations were identified and subsequently characterized by DNA sequencing. One undifferentiated carcinoma displayed two areas with varying degrees of differentiation. The comparative analysis of the p53 gene, in both the more and the less differentiated area of this tumor, clearly showed that the p53 mutation was confined to the latter component of the tumor specimen. These results indicate that mutations of the p53 gene are associated with the most aggressive histologic types of thyroid tumors, such as the undifferentiated carcinoma and, to a certain extent, the poorly differentiated carcinoma, and that the alterations of this gene represent a late genetic event in human thyroid carcinogenesis.
R Donghi, A Longoni, S Pilotti, P Michieli, G Della Porta, M A Pierotti
Title and authors | Publication | Year |
---|---|---|
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
E Molinaro, C Romei, A Biagini, E Sabini, L Agate, S Mazzeo, G Materazzi, S Sellari-Franceschini, A Ribechini, L Torregrossa, F Basolo, P Vitti, R Elisei |
Nature Reviews Endocrinology | 2017 |
ZCCHC12, a novel oncogene in papillary thyroid cancer
O Wang, Z Zheng, Q Wang, Y Jin, W Jin, Y Wang, E Chen, X Zhang |
Journal of Cancer Research and Clinical Oncology | 2017 |
Diagnostic Molecular Pathology
RC Arcenas |
Diagnostic Molecular Pathology | 2017 |
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
B Bonhomme, Y Godbert, G Perot, AA Ghuzlan, S Bardet, G Belleannée, L Crinière, CD Cao, G Fouilloux, S Guyetant, A Kelly, S Leboulleux, C Buffet, E Leteurtre, JJ Michels, F Tissier, ME Toubert, M Wassef, C Pinard, I Hostein, I Soubeyran |
Thyroid | 2017 |
Oncogenesis of Thyroid Cancer
Enas Younis |
Asian Pacific Journal of Cancer Prevention | 2017 |
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA
DS Duick, RA Levine, MA Lupo |
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA | 2017 |
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden, D Biase, A Pession, T Giovanni |
Histopathology | 2017 |
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis
YS Song, CK Jung, KC Jung, YJ Park, JK Won |
Journal of Korean Medical Science | 2017 |
Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies
NA Cipriani, S Agarwal, D Dias-Santagata, WC Faquin, PM Sadow |
Thyroid | 2017 |
The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration
S Mertsch, OH Krämer |
Cytokine & Growth Factor Reviews | 2017 |
Glycolysis-related protein expression in thyroid cancer
JH Nahm, HM Kim, JS Koo |
Tumor Biology | 2017 |
New perspectives in the diagnosis of thyroid follicular lesions
E Baldini, S Sorrenti, F Tartaglia, A Catania, A Palmieri, D Pironi, A Filippini, S Ulisse |
International journal of surgery (London, England) | 2017 |
Gene master regulators of papillary and anaplastic thyroid cancers
DA Iacobas, NY Tuli, S Iacobas, JK Rasamny, A Moscatello, J Geliebter, RK Tiwari |
Oncotarget | 2017 |